SUBSCRIBE
SUBSCRIBE
News   Business

Stryker Corporation Gets FDA Warning Letter for Ireland Plant

June 20, 2007 | 
1 min read
CHICAGO, June 19 (Reuters) - U.S. regulators sent Stryker Corp. a warning letter, saying the artificial hip and knee maker has not completed promised fixes at a plant in Ireland, according to a letter posted by regulators on Tuesday.
Real estate Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
World Management Team in office silhouette 3d rendering
Drug Development
The Gap Between the Administration’s Pro-Innovation Words and Policy
July 14, 2025
 · 
6 min read
 · 
Lori Ellis
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Massachusetts-Based Karyopharm, Azurity Cut Workforces
July 14, 2025
 · 
158 min read
 · 
BioSpace Editorial Staff
Contemporary art collage. Giang hand kicking office worker symbolizing dismissal. Unsuccessful employee. Job reduction. Concept of business, career, failure, success, troubles
Rare diseases
Ultragenyx Takes Second Hit as FDA Rejects Gene Therapy for Sanfilippo Syndrome
July 14, 2025
 · 
2 min read
 · 
Tristan Manalac
Regulatory
FDA Mulls Speedier Reviews to Companies Willing To Lower Drug Costs
July 14, 2025
 · 
1 min read
 · 
Tristan Manalac